ARPA-H, part of HHS, has earmarked up to $142 million for 10 research projects building the tools, data, and infrastructure needed to tackle treatment resistance.

Based on data from the BEACON and NAUTICAL studies, regulatory authorities greenlit the combo for later-line patients.

Investing.com -- PDS Biotechnology Corp (NASDAQ: PDSB) stock rose 3.8% after the company announced that its clinical trial for metastatic colorectal cancer treatment has met pre-set criteria for ...

"Colonoscopy is considered the gold-standard when screening for colorectal cancer," says gastroenterologist Dr. Brian McGee, ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

While oncology has relentlessly pursued progress through pharmacological and procedural advances, exercise has occupied a ...

Individuals with ulcerative colitis have an increased risk for certain types of cancer based on age, instead of treatment type.

Approval was based on results from the DOORwaY90 trial, which demonstrated a 98.5% overall response rate and 100% local tumor control in patients treated with the SIR-Spheres Y-90 resin microspheres ...

Rates of colorectal and other gastrointestinal cancers are rising in Americans under the age of 50, researchers said Tuesday.

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

("LIXTE” or the "Company”) (Nasdaq: LIXT and LIXTW), a clinical stage pharmaceutical company, today announced that the ...

Colon cancer is spiking in young adults. Scientists are blaming the American diet - Nearly 53,000 Americans expected to die from colorectal cancer this year ...